Ledger.Open graph →
SEC Form D · filed June 4, 2019

Phi Therapeutics, Inc

Offering
$1.6M
Sold
$575K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Maria S. Cho · San Francisco, CAExec · DirectorJun S. Li · Palo Alto, CADirectorYug Varma · San Francisco, CAExec · DirectorJoan D. Clarke · Prince George, VAExec · DirectorG. N. Baird · Prince George, VADirectorRudy L. Hawkins · Prince George, VAExec · DirectorJoshua Feast · Boston, MAExec · DirectorMark Midle · Boston, MAExec · DirectorDavid Klein · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗